首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Comparison of the effects of repetitive low-dose and single-dose antigen challenge on airway inflammation.
【24h】

Comparison of the effects of repetitive low-dose and single-dose antigen challenge on airway inflammation.

机译:重复性小剂量和单剂量抗原攻击对气道炎症的作用比较。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Airway allergen provocation provides a model to study allergic inflammation in relationship to pulmonary physiology. Allergen provocation is usually administered as a relatively large single-dose challenge that might not reflect a chronic, natural, low-dose airborne allergen exposure. OBJECTIVE: We sought to compare the magnitude, characteristic features, and kinetics of airway inflammation induced by means of repetitive low-dose antigen challenges with those factors induced by means of an equivalent single-dose allergen challenge in allergic asthma. METHODS: This was a 2-period crossover study. During separate phases, each subject was administered either a predetermined single-dose antigen challenge or 25% of that dose on each of 4 consecutive days. The airway response to allergen challenge was determined by means of measurement of pulmonary function and sputum features of inflammation, including eosinophil, eosinophil-derived neurotoxin, and fibronectin levels. RESULTS: Both models of antigen challenge caused significant and equivalent sputum eosinophilia. The immediate decrease in FEV(1) and the FEV(1)/forced vital capacity ratio and the increase in sputum eosinophilia, eosinophil-derived neurotoxin, and fibronectin levels occurred gradually over the first 3 low doses and then reached a plateau or tended to decrease with the fourth antigen exposure. CONCLUSION: Our data suggest that although the 2 challenge models had similar quantitative effects on lung function and sputum eosinophilia, the qualitative responses and kinetics of these changes were distinct. Repetitive low doses of antigen, as might mimic natural allergy exposure, produced an equivalent inflammatory response to the large single-dose challenge but with a smaller amount of antigen, suggesting that priming and accumulative effects might have occurred. Moreover, our limited data also suggest that immunologic tolerance might be induced by frequent challenges.
机译:背景:气道过敏原激发提供了一种模型,用于研究与肺生理相关的过敏性炎症。过敏原激发通常是相对较大的单剂量试验,可能无法反映出长期,自然,低剂量的空气传播过敏原暴露。目的:我们试图比较重复性小剂量抗原挑战引起的气道炎症的程度,特征和动力学,以及过敏性哮喘中等效单剂量过敏原挑战引起的因素。方法:这是一个为期2个交叉的研究。在单独的阶段中,每位受试者在连续4天的每一天都接受预定的单剂量抗原攻击或该剂量的25%。通过测量肺功能和炎症的痰液特征(包括嗜酸性粒细胞,嗜酸性粒细胞衍生的神经毒素和纤连蛋白水平)来确定气道对过敏原激发的反应。结果:这两种抗原激发模型都引起明显和相等的痰嗜酸性粒细胞增多。 FEV(1)和FEV(1)/强迫肺活量比率的立即下降以及痰中嗜酸性粒细胞增多,嗜酸性粒细胞衍生的神经毒素和纤连蛋白水平的增加在前3次低剂量后逐渐发生,然后达到平稳或趋于随着第四次抗原暴露而减少。结论:我们的数据表明,尽管这两种挑战模型对肺功能和痰嗜酸性粒细胞增多具有相似的定量作用,但这些变化的定性反应和动力学是截然不同的。重复的低剂量抗原(可能模仿自然过敏暴露)对大剂量单剂量刺激产生了等效的炎症反应,但抗原量较小,表明可能已经发生了引发和累积作用。此外,我们有限的数据还表明免疫耐受可能是由于频繁的挑战而引起的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号